Immune function and response to neoadjuvant chemotherapy in hormone receptor positive, HER2-negative breast cancerShow others and affiliations
2017 (English)In: Annals of Oncology, ISSN 0923-7534, E-ISSN 1569-8041, Vol. 28, no Suppl. 5, article id 219PArticle in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Oxford University Press, 2017. Vol. 28, no Suppl. 5, article id 219P
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:oru:diva-61639ISI: 000411324000209OAI: oai:DiVA.org:oru-61639DiVA, id: diva2:1150205
Conference
42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, Spain, September 8-12, 2017
Funder
Swedish Cancer Society
Note
Funding Agencies:
Clinical Research within the National Health Service
Roche Sweden AB
BioCARE
2017-10-182017-10-182018-08-06Bibliographically approved